Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Diclofenac pharmacological

A close structural analog of the non-selective COX inhibitor diclofenac, lumiracoxib displays a 500-fold greater selectivity for COX-2 than COX-1 in vivo and exhibits a unique pharmacologic profile that includes rapid absorbance and a relatively short plasma half-life (41, 42). Lumiracoxib lacks the tricyclic structure of the diarylheterocycle class of COX-2 selective inhibitors (e.g., celecoxib and rofecoxib) and does not contain a sulfonamide or sulfone group. Although structurally related, lumiracoxib and diclofenac exhibit large differences in the selectivity of COX-2 inhibition, and the molecular basis for this... [Pg.304]

Van HA, Schwartz Jl, Depre M et al. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. Journal of Clinical Pharmacology 2000 40 1109-1120. [Pg.450]

Dilger K, Herriinger C, Peters J et al. Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects. Journal of Clinical Pharmacology 2002 42 985-994. [Pg.455]

All compounds of the test dataset are nonsteroidal anti-inflammatory drugs (NSAIDs) and are thus relatively similar in terms of their pharmacological properties (Fig. 18). The compounds are 1, acetylsalicylic acid 2, diclofenac 3, flufe-namic acid 4, flubiprofen 5, ibuprofen 6, indometacin 7, ketoprofen 8, meclofe-namic acid 9, mefenamic acid 10, naproxen 11, piroxicam 12, sulindac sulfide (active metabolite of sulindac) 13, tenoxicam 14, meloxicam 15, cgp 28238 16, DuP-697 17, L-745-337 18, 6-methoxy-2-naphthylacetic acid (active metabolite of nabumeton) 19, NS-389 20, SC 58125. [Pg.599]

Tolmetin sodium is a NSAID, which decreases inflammation, pain, and fever, probably through inhibition of cyclooxygenase activity and prostaglandin synthesis. It is indicated in the treatment of chronic and acute rheumatoid arthritis and osteoarthritis and juvenile rheumatoid arthritis. Tolmetin and ketoroiac are structurally related heteroaryl acetic acid derivatives with different pharmacological features. Diclofenac is a phenylacetic acid derivative that was developed specifically as an antiinflammatory agent. [Pg.696]

Tolmetin and ketorolac are structurally related heteroaryl acetic acid derivatives with different pharmacological features. Diclofenac is a phenylacetic acid derivative that was developed specifically as an anti-inflammatory agent. [Pg.449]

Celecoxib is currently indicated for the relief of signs and symptoms of osteoarthritis and rheumatoid arthritis and to reduce the number of adenomatous colorectal polyps in familial adenomatous polyposis as an adjunct to usual care. Celecoxib is at least as effective as naproxen in the symptomatic management of osteoarthritis and at least as effective as naproxen and diclofenac in the symptomatic treatment of rheumatoid arthritis, and it is less likely to cause adverse Gl effects. Celecoxib appears to be effective in the management of pain associated with both of these arthritic conditions, but effectiveness in acute or chronic pain has not been fully demonstrated. Unlike aspirin, celecoxib does not exhibit antiplatelet activity. Concomitant administration of aspirin and celecoxib may increase the incidence of Gl side effects. Another notable potential drug interaction with celecoxib is its ability, like other NSAIDs, to reduce the blood pressure response to angiotensin-converting enzyme inhibitors. A more detailed discussion of the chemical, pharmacological, pharmacokinetic, and clinical aspects of celecoxib is available (81). [Pg.1482]

Cwiertnia, B, T Hladon and M Stobiecki (1999). Stability of diclofenac sodium in the inclusion complex in the beta cydodextrin in the solid state. Journal of Pharmacy and Pharmacology, 51,1213-1218. [Pg.232]

Report B 4 /1983. Diclofenac-Na Distribution in the rabbit eye. Pharma Research and Development Pharmacological Chemistry. Ciba-Geigy limited. Basle. 1983. [Pg.164]

Curcio et al. prepared microspheres of diclofenac sodium using PNlPAAm grafted with gelatin. PNlPAAm suffers with the limitation of low LCST of 32°C. Thus, in order to enhance its LCST close to the body temperature the PNlPAAm was grafted with gelatin. The LCST of polymer was enhanced and a sustained release profile of drug was achieved and the pharmacological effect of the NSAID was enhanced [35]. [Pg.747]


See other pages where Diclofenac pharmacological is mentioned: [Pg.177]    [Pg.200]    [Pg.160]    [Pg.325]    [Pg.45]    [Pg.236]    [Pg.2380]    [Pg.117]    [Pg.71]    [Pg.486]    [Pg.1463]    [Pg.1483]    [Pg.279]    [Pg.231]    [Pg.71]    [Pg.416]    [Pg.1251]    [Pg.268]    [Pg.59]    [Pg.232]    [Pg.494]   
See also in sourсe #XX -- [ Pg.432 ]




SEARCH



Diclofenac

© 2024 chempedia.info